Rs3802278 in 3’-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients-Reference-Cited by-同舟云学术

Rs3802278 in 3’-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients

Author:

Zeng Feiyue¹,Liu Yujie²³⁴⁵,Ouyang Qianying²³⁴⁵,Sun Zeen²³⁴⁵,Zhang Keqiang⁶,Li Xi²³⁴⁵,Liu Yingzi²³⁴⁵

Affiliation:

1. Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China

2. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China

3. Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan, P. R. China

4. Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, Hunan, P. R. China

5. National Clinical Research Center for Geriatric Disorders, Changsha, Hunan, P. R. China

6. Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

Reference28 articles.